Seqens Seqens

X

Digital content for Sareum

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Sareum
unitedkingdom_new Flag
Country
Country
United Kingdom
Address
Address
Unit 2A, Langford Arch London Road, Pampisford Cambridge CB22 3FX
Telephone
Telephone
+44 (0) 1223 497700

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.clinicaltrialsarena.com/news/sareum-approval-sdc-1801-australia/

CLINICAL TRIALS ARENA
05 May 2023

https://www.globenewswire.com/news-release/2022/07/28/2487660/0/en/Sareum-submits-Clinical-Trial-Authorisation-application-to-UK-MHRA-for-development-of-TYK2-JAK1-inhibitor-SDC-1801-and-provides-an-Operational-Update.html

GLOBENEWSWIRE
28 Jul 2022

http://www.sareum.com/news/press-releases-and-news/2022/sareum-present-biotrinity-2022-conference/

PRESS RELEASE
26 Apr 2022

http://www.sareum.com/news/press-releases-and-news/2022/sareum-notes-proposed-acquisition-sierra-oncology-gsk/

PRESS RELEASE
13 Apr 2022

http://www.sareum.com/news/press-releases-and-news/2022/european-patent-granted-sareums-sdc-1802/

PRESS RELEASE
11 Apr 2022

http://www.sareum.com/news/press-releases-and-news/2021/subscription-raise-163m-progress-sdc-1801/

SAREUM
17 Dec 2021

https://www.investegate.co.uk/sareum-holdings-plc--sar-/rns/us-patent-granted-for-sdc-1802-tyk2-jak1-inhibitor/202110071042533573O/

INVESTEGATE
07 Oct 2021

https://www.rttnews.com/Products/BiotechInvestor/Story.aspx?ID=3231096&PageNum=1&type=bidd

RTTNEWS
07 Oct 2021

http://www.sareum.com/news/press-releases-and-news/2020/covid-19-research-grant-confirmed/

SAREUM
04 Dec 2020

http://www.sareum.com/news/press-releases-and-news/2020/us-patent-allowance-sdc-1802-tyk2jak1-inhibitor/

PRESSRELEASE
08 Oct 2020
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY